RenMice-based 6 Fully Human Antibody Discovery Platforms
Based on the RenMiceTM (RenMabTM, RenLite® and RenNano®) platforms, Biocytogen has established six fully human antibody technology platforms to meet multiple targets and multiple proprietary forms of antibody drug development